Association of IL-17A levels with immuneinflammatory profile and structural MRI data in patients with schizophrenia

IL-17A is a proinflammatory cytokine involved in pathogenesis of some neuroinflammatory diseases of the brain. However, its role in schizophrenia is poorly understood. Currently, noninvasive neuroimaging techniques are widely used to assess abnormalities in brain morphology and interactions of neuro...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. K. Malashenkova, V. L. Ushakov, S. A. Krynskiy, D. P. Ogurtsov, N. A. Khailov, A. Yu. Ratushnyy, E. I. Chekulaeva, N. V. Zakharova, G. P. Kostyuk, N. A. Didkovsky
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2022-12-01
Series:	Медицинская иммунология
Subjects:	cytokines cortical thickness inflammation interleukin-17a magnetic resonance imaging schizophrenia
Online Access:	https://www.mimmun.ru/mimmun/article/view/2528
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Thinning of the temporal and insular cortex is associated with negative symptoms and impaired attention in Chinese chronic schizophrenia patients with deficit syndrome
by: Jin Li, et al.
Published: (2025-04-01)

Altered cortical thickness associated with psychotic symptoms and cognitive profiles in involuntarily hospitalized, first-episode, drug-naive patients with schizophrenia
by: Ruru Tang, et al.
Published: (2025-06-01)

Measurement of Limbic System Anatomical Volumes in Patients Diagnosed with Schizophrenia Using Vol2brain and Comparison with Healthy Individuals
by: Mert Ocak, et al.
Published: (2025-03-01)

Levels of chemokines and other inflammatory mediators in patients with mild cognitive impairment undergoing rehabilitation
by: I. K. Malashenkova, et al.
Published: (2023-06-01)

Structural and functional characteristics of the T helpers 17 subpopulation in allergic diseases of the respiratory organs in children
by: E. V. Prosekova, et al.
Published: (2020-01-01)

INTERLEUKIN-18 LEVELS IN SCHIZOPHRENIA PATIENTS RECEIVING ANTI-PSYCHOTIC THERAPY AT THE PSYCHIATRIC POLYCLINIC OF SITI RAHMAH ISLAMIC HOSPITAL
by: Dita Hasni, et al.
Published: (2025-01-01)

The role of interleukin 17 in the pathogenesis of rheumatoid arthritis. Are there any prospects for the use of IL-17 inhibitors?
by: E. L. Nasonov, et al.
Published: (2023-04-01)

Biochemical disturbances in schizophrenia — a «window of opportunity»
by: T. V. Zhilyaeva, et al.
Published: (2022-12-01)

Use of the interleukin-17A inhibitor secukinumab in psoriatic arthritis: a subanalysis of the Russian population in the international randomized clinical trials FUTURE 1 and FUTURE 2
by: T. V. Korotaeva, et al.
Published: (2017-04-01)

Course of uveitis in patients with ankylosing spondylitis during the interleukin 17 inhibitors therapy
by: A. A. Godzenko, et al.
Published: (2023-10-01)

The effect of interleukin-17 on the course of juvenile idiopathic arthritis
by: Oshlyanska, O., et al.
Published: (2024-12-01)

Efficacy of interleukin-17 inhibitors in psoriasis patients: a comparative non-randomized study
by: Arfenya E. Karamova, et al.
Published: (2025-06-01)

The role of interleukin 17 in the pathogenesis of giant cell arteritis: new possibilities for pharmacotherapy
by: E. L. Nasonov, et al.
Published: (2024-12-01)

Interleukin-6 in schizophrenia is associated with negative symptoms, side effects of therapy and smoking: results of a pilot study
by: T. V. Zhilyaeva, et al.
Published: (2022-07-01)

The impact of chronic stress on cortical thickness in patients with depression
by: Na Li, et al.
Published: (2025-07-01)

Danggui Beimu Kushen Pill Alleviates Colitis-Induced Inflammation in Mice by Regulating the IL-6/IL-6R and IL-17A/IL-17RA Signaling Pathways
by: Shuo Gong, et al.
Published: (2025-01-01)

Salivary Levels of Interleukin-17 in Iranian Patients With Systemic Sclerosis
by: Ali Tadayon, et al.
Published: (2024-12-01)

Interleukin-17 signaling influences CD8+ T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cells
by: Constanza Rodriguez, et al.
Published: (2023-12-01)

Pattern of Interleukin-17A and Interleukin-1β in Migraine Patients
by: Fardin Faraji, et al.
Published: (2024-08-01)

Efficacy and safety of netakimab in patients with psoriatic arthritis: results of the phase III PATERA clinical study
by: T. V. Korotaeva, et al.
Published: (2020-11-01)

Efficacy of netakimab in key psoriatic arthritis domains: 54-week results from the phase III BCD-085-8/PATERA study
by: T. V. Korotaeva, et al.
Published: (2021-03-01)

Altered brain complexity in first-episode antipsychotic-naïve patients with schizophrenia: A whole-brain voxel-wise study
by: Naici Liu, et al.
Published: (2024-01-01)

INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes
Published: (2016-09-01)

Review of mechanisms and frontier applications in IL-17A-induced hypertension
by: Li Ruiyuan, et al.
Published: (2025-02-01)

Suicidal risk in patients with aggression in schizophrenia: a systematic review
by: Lidia Bravve, et al.
Published: (2025-04-01)

Acute Schizophrenia-like Psychotic Disorder Against the Background of COVID-19
by: Lidia Bravve, et al.
Published: (2025-02-01)

Features of the cytokine profile in children with autism spectrum disorder
by: M. I. Khudiakova, et al.
Published: (2021-01-01)

Mapping Genetic Associations With Functional Brain Area Alterations in Schizophrenia and Implications for Cortical Development
by: Jun‐Ding Zhu, et al.
Published: (2025-07-01)

The Pivotal Role of Interleukin-17 in the Pathogenesis of Systemic Lupus Erythematosus
by: Duaa Sami Segatri, et al.
Published: (2025-06-01)

Netakimab for the treatment of psoriatic arthritis: 3-year results of the phase III BCD-085-8/PATERA study
by: T. V. Korotaeva, et al.
Published: (2024-08-01)

Long-term efficacy and safety of netakimab in patients with active ankylosing spondylitis: results of three years of use in the international multicentre, randomized, double-blind, phase III clinical trial BCD-085-5/ASTERA
by: V. I. Mazurov, et al.
Published: (2024-02-01)

Research advances in functional roles of Th17 and IL-17 in acute kidney injury
by: Pang Hao-wen, et al.
Published: (2021-01-01)

Expression analysis of the IL-23/Th17 pathway in children with rhinovirus infection
by: Shu Teng, et al.
Published: (2025-07-01)

Effects of electroconvulsive therapy on serum brain derived neurotrophic factor, serum interleukin-6, and serum cortisol levels in patients with treatment refractory schizophrenia
by: Nikhil Gurjar, et al.
Published: (2025-01-01)

Neurocognitive impairments in patients with schizophrenia and schizophrenia spectrum disorders: cluster analysis results
by: M. V. Karyakina, et al.
Published: (2020-04-01)

Long-term efficacy and safety of netakimab in the treatment of ankylosing spondylitis: results of Phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA
by: V. I. Mazurov, et al.
Published: (2020-11-01)

Brain Structural Correlates of EEG Network Hyperexcitability, Symptom Severity, Attention, and Memory in Borderline Personality Disorder
by: Andrea Schlump, et al.
Published: (2025-05-01)

Sublinear association between cortical thickness at the onset of the adult lifespan and age-related annual atrophy parallels spatial patterns of laminar organization in the adult cerebral cortex
by: Bruno Hebling Vieira, et al.
Published: (2021-06-01)

Late schizophrenia
by: V. E. Pashkovskiy
Published: (2020-12-01)

Levels of different cytokines in women and men with asymptomatic genital infection caused by Chlamydia
by: Alessandra Bua, et al.
Published: (2019-09-01)